Anticonvulsant activity of some xanthone derivatives

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 15, 2008, Pages 7234-7244

  Marona, Henryk ^a   Pekala, Elzbieta ^a   Antkiewicz Michaluk, Lucyna ^b   Walczak, Maria ^a   Szneler, Edward ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Anticonvulsive activities; Enantiopurity; Radioligand binding assay; Xanthones

Indexed keywords

2 (9 OXO 9H XANTHENE 2 CARBOXAMIDO) ACETATE; 6 CHLORO 2 [(1 CHLOROPROPAN 2 YL(AMINO)METHYL] 9H XANTHEN 9 ONE HYDROCHLORIDE; 6 CHLORO 2 [(2 HYDROXYETHYLAMINO)METHYL] 9H XANTHEN 9 ONE; 6 CHLORO 2 [(2 HYDROXYPROPYLAMINO)METHYL] 9H XANTHEN 9 ONE; 6 CHLORO 2 [(3 HYDROXYPROPYLAMINO)METHYL] 9H XANTHEN 9 ONE HYDROCHLORIDE; 6 CHLORO 2 [(4 HYDROXY 2 METHYLBUTAN 2 YLAMINO)METHYL] 9H XANTHEN 9ONE; 6 CHLORO 2 [(5 HYDROXYPENTYLAMINO)METHYL] 9H XANTHEN 9 ONE; 6 CHLORO 2 [[(1 CHLOROPROPAN 2 YL)(METHYL)AMINO]METHYL] 9H XANTHEN 9 ONE; 6 CHLORO 2 [[(1 HYDROXYPROPAN 2YL)(METHYL)AMINO]METHYL] 9H XANTHEN 9 ONE; 6 CHLORO 2 [[(2 HYDROXYETHYL)(METHYL)AMINO]METHYL] 9H XANTHEN 9 ONE; 6 CHLORO 2 [[ETHYL(2 HYDROXYETHYL)AMINO]METHYL] 9H XANTHEN 9 ONE; 6 CHLORO 2 METHYLXANTHONE; 6 CHLORO 2[(2 HYDROXYBUTYLAMINO)METHYL] 9H XANTHEN 9 ONE; 6 CHLORO N (1 HYDROXYPROPAN 2 YL) 9 OXO 9H XANTHENE 2 CARBOXAMIDE; 6 CHLOROXANTHONE; BENZODIAZEPINE RECEPTOR; CARBAMAZEPINE; CHLORO 2 (1 HYDROXYBUTAN 2 YLAMINO)METHYL 9H XANTHEN 9 ONE; DIAZEPAM; N (1 HYDROXYPROPAN 2 YL) 9 OXO 9H XANTHENE 2 CARBOXAMIDE; N (2 AMINO 2 OXOETHYL) 9 OXO 9H XANTHENE 2 CARBOXAMIDE; N (2 HYDROXYCYCLOHEXYL) 9 OXO 9H XANTHENE; N (4 HYDROXYBUTYL) 9 OXO 9H XANTHENE 2 CARBOXAMIDE; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID; VOLTAGE GATED CALCIUM CHANNEL; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ELECTRIC SHOCK; ENANTIOMER; IN VITRO STUDY; LIGAND BINDING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NEUROTOXICITY; NONHUMAN; RADIOASSAY; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; MICE; MOLECULAR STRUCTURE; PENTYLENETETRAZOLE; RATS; SEIZURES; XANTHONES;

MUS; RATTUS;

EID: 48449106288     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.06.039     Document Type: Article

References (27)

1. Singh P., and Huot J. Anticonvulsant Drugs Vol. 2 (1973), J.E.P.T. Pergamon, New York p 427
2. Willow M., Kuenzel E.A., and Catterall W.A. Mol. Pharmacol. 25 (1983) 228
3. Bowery N.G. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 109
4. Hollmann M., and Heinemann S. Annu. Rev. Neurosci. 17 (1994) 31
5. Nakanishi S., and Masu M. Annu. Rev. Biophys. Biomol. Struct. 23 (1994) 319
6. Takahashi M., Billups B., Rossi D., Sorentis M., Hamann M., and Atwell D.J. Exp. Biol. 200 (1997) 401
7. Quintas S., Garcia A., and Dominguez D. Tetrahedron Lett. 44 (2003) 9291
8. Pflister J.R., Ferraresi R.W., Harrison I.T., Rooks W.H., Roszkowski A.P., Van Horn A., and Fried J.H. J. Med. Chem. 15 (1972) 1032
9. Gion R.M., Valenti P., Montanasi P., and Da Re P. Arzneim.-Forsch./Drug Res. 32 (1982) 499
10. Sato H., Dan T., Onuma E., Tanaka H., and Koga H. Chem. Pharm. Bull. 38 (1990) 1266
11. Castanheiro R., Pinto M., Silva S., Cravo S., Gales L., Damas A., Nazareth N., Nascimento M., and Eaton G. Bioorg. Med. Chem. 15 (2007) 6080
12. Saraiva L., Fresco P., Pinto E., Sousa E., Pinto M., and Goncalves J. Bioorg. Med. Chem. 11 (2003) 1215
13. Salmoiraghi J., Rossi M., Valenti P., and Da Re P. Arch. Pharm. Pharm. Med. Chem. 331 (1998) 225
14. Moreau S., Varache-Lembege M., Larrouture S., Fall D., Neveu A., Deffieux G., Vercauteren J., and Nuhrich A. Eur. J. Med. Chem. 37 (2002) 237
15. Fukai T., Oku Y., Yonekawa M., and Terada S. Phytomedicine 6-7 (2005) 510
16. Marona H. Pharmazie 53 (1998) 672
17. Marona H. Pharmazie 53 (1998) 405
18. Marona H., and Antkiewicz-Michaluk L. Acta Polon. Pharm.-Drug Res. 55 (1998) 487
19. Librowski T., Czarnecki R., Jastrze{ogonek}bska-Wie{ogonek}sek M., Opoka W., and Marona H. Boll. Chim. Farmac. 143 (2004) 267
20. Porter R.J., Cereghino J.J., Gladding G.D., Hessie B.J., Kupferberg H.J., Scoville B., and White B.G. Cleve. Clin. Q. 51 (1984) 293
21. Mulzac D., and Scott K.R. Epilepsia 34 (1993) 1141
22. Kalinina N.N., Kritsyn A.M., Likhosherstow A.M., Protopopowa T.B., and Skoldinow A.P. Med. Prom. SSSR 66 (1963) 9133c
23. Kambe S., and Yasuda H. Bull. Chem. Soc. Jpn. 41 (1968) 1444
24. Gajewczyk L., and Zejc A. Pol. J. Chem. 64 (1990) 567
25. Eckstein M., and Marona H. Pol. J. Pharmacol. Pharm. 54 (1980) 1281
26. Eckstein M., Marona H., and Mazur J. Pol. J. Pharmacol. Pharm. 35 (1983) 159
27. Krall R., Penry J., White B., Kupferberg H., and Swinyard E. Epilepsia 19 (1978) 400